Do No Harm Report Reveals Lack of Guardrails Preventing Minors from Obtaining Cross-Sex Hormones Online
SALT LAKE CITY, UTAH; March 10, 2026 – Today, medical watchdog Do No Harm released a report titled “The Lack of Barriers to Minors Ordering Cross-Sex Hormones Online,” exposing how online pharmacies may enable minors to access sex-denying interventions without a prescription or age verification.
The report also urges the Food and Drug Administration (FDA) to further investigate and regulate online pharmacies selling hormones without requiring prescriptions.
Do No Harm’s report warns about several avenues – including online forums and gender transition websites – where minors can learn how to access and self-administer cross-sex hormones. The report stresses the dangers facing gender-confused children who seek cross-sex hormones from the internet.
Click here to read the report.
“Our report reveals how online pharmacies may enable minors to obtain cross-sex hormones with alarming ease,” said Kurt Miceli, MD, Chief Medical Officer at Do No Harm. “From websites listing online vendors across the globe to marketplaces for ‘homebrewed’ hormones, we found a multitude of troubling pathways that appear to bypass basic safeguards and regulatory oversight. Gender-confused kids should not be able to purchase potent, experimental medications with just a few simple clicks. These hormones carry significant risks, including effects that can be irreversible. We urge the FDA and other federal agencies to investigate any potential unlawful sellers and, where appropriate, for states to do the same when their laws are being violated. Protecting minors from unsafe and unregulated access to powerful cross-sex hormones must remain a priority.”
Key Findings:
- DIYHRT.Market: A database of pharmacies and “homebrewers” that appear to lack proper safeguards preventing minors from accessing cross-sex hormones.
- HRT Cafe: A resource website listing “unregulated” pharmacies and hormone vendors that do not require prescriptions.
- Inhouse Pharmacy: A foreign online pharmacy that boasts a dedicated product webpage for transgender-related drugs and states that it is “permitted” to process orders without prescriptions.
Do No Harm has previously exposed the dangers of hormonal interventions on minors. This report calls upon the FDA to investigate and further monitor online vendors, urges federal lawmakers to develop more restrictive legislation as necessary, and asks the states to prosecute online sellers that violate existing restrictions on cross-sex hormones.
Do No Harm, established in April 2022, has rapidly gained recognition and made significant strides in its mission to safeguard healthcare from ideological threats. It has over 50,000 members, including doctors, nurses, physicians, and concerned citizens across all 50 states and 14 countries.

